Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP13 | P45452 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | JMJD6 | Q6NYC1 | 3/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.45 |
| ▸ | GABRP | O00591 | 5/20 | 0.45 |
| ▸ | GABRD | O14764 | 5/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.45 |
| ▸ | GABRB1 | P18505 | 5/20 | 0.45 |
| ▸ | GABRG2 | P18507 | 5/20 | 0.45 |
| ▸ | GABRB3 | P28472 | 5/20 | 0.45 |
| ▸ | GABRA5 | P31644 | 5/20 | 0.45 |
| ▸ | GABRA3 | P34903 | 5/20 | 0.45 |
| ▸ | GABRA2 | P47869 | 5/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.45 |
| ▸ | GABRA4 | P48169 | 5/20 | 0.45 |
| ▸ | GABRE | P78334 | 5/20 | 0.45 |
| ▸ | GABRA6 | Q16445 | 5/20 | 0.45 |
| ▸ | GABRG1 | Q8N1C3 | 5/20 | 0.45 |
| ▸ | GABRG3 | Q99928 | 5/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL930636 | 0.89 | JMJD6 (0.57) | CYP1A2JMJD6PIK3CAGABRPGABRD | |
| SCHEMBL29466587 | 0.89 | JMJD6 (0.57) | CYP1A2JMJD6PIK3CAGABRPGABRD | |
| SCHEMBL581406 | 0.88 | JMJD6 (0.57) | CYP1A2JMJD6PIK3CANPC1RAB9A | |
| SCHEMBL9297593 | 0.86 | CYP1A2 (0.49) | CYP1A2JMJD6PIK3CAGABRPGABRD | |
| SCHEMBL1920448 | 0.86 | FTO (0.61) | CYP1A2JMJD6PIK3CAGABRPGABRD | |
| SCHEMBL20963551 | 0.85 | JMJD6 (0.44) | CYP1A2JMJD6PIK3CAGABRPGABRD | |
| SCHEMBL29278613 | 0.85 | JMJD6 (0.44) | CYP1A2JMJD6PIK3CAGABRPGABRD | |
| SCHEMBL24604371 | 0.83 | CYP1A2 (0.46) | CYP1A2JMJD6PIK3CAGABRPGABRD | |
| SCHEMBL3062909 | 0.81 | ALDH1A1 (0.50) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| Bromide SCHEMBL9298199 | 0.81 | JMJD6 (0.44) | CYP1A2JMJD6PIK3CAGABRPGABRD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8188085-B2 | Antifungal agents | MERCK SHARP & DOHME CORP. (US) | 2012-05-29 | — | — | US | disclosed |
| US-20100113439-A1 | Antifungal agents | MERCK & CO., INC. (US) | 2010-05-06 | — | — | US | disclosed |
| WO-2010019204-A1 | ANTIFUNGAL AGENTS | MERCK SHARP & DOHME CORP. (US) | 2010-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113439-A1 | Antifungal agents | GMDS, GBA3, UGGT1 | MMP2 1070/4885MMP13 1527/4885CYP1A2 623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.